Professor Lisa Stehno-Bittel

Likarda, LLC

Lisa Stehno-Bittel on using 3D Cell Cultures for Efficacy & Toxicity Screening

Prof. Lisa Stehno-Bittel, President and CEO of Likarda describes the use of 3D cell cultures and 3D cell imaging for screening drugs for efficacy and toxicity.

LIKE 0


Professor Lisa Stehno-Bittel
Automated Liquid Handling

Professor Lisa Stehno-Bittel

Biography

Lisa Stehno-Bittel, PT,... More
Follow Lisa

Professor Lisa Stehno-Bittel

Likarda, LLC

Lisa Stehno-Bittel, PT, Ph.D., serves as director of a medical imaging course for physical therapy and audiology students as well as for an administration course for physical therapists at the University of Kansas Medical Center. In 2012, Lisa licensed her laboratory patents from the University of Kansas and co-founded the biotech company, Likarda, which was named one of the 50 most promising start-ups in the world during Global Entrepreneur week. The patents had applications in drug screening for efficacy and toxicity, as well as the ability to transform cell-based therapeutics. Since then Likarda has grown to provide drug discovery and product testing services – as well as produce cell-based therapies – for companion animals.